Blocking the electron transport chain complex I with the selective inhibitor EVT-701 decreased the expression of CD39 and PD-L1 in THP1, MOLM-13, C1498, and L1210 AML cells in vitro (160). This evidence concerns the gene CD274 and acute myeloid leukemia.